Clobetasone

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
Image:Clobetasone.png
Clobetasone
Systematic (IUPAC) name
(8S,9R,10S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-17-hydroxy-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthrene-3,11-dione
Identifiers
CAS number 54063-32-0
ATC code D07AB01 S01BA09
PubChem 71387
Chemical data
Formula C22H26ClFO4 
Mol. mass 408.891
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes topical

WikiDoc Resources for

Clobetasone

Articles

Most recent articles on Clobetasone

Most cited articles on Clobetasone

Review articles on Clobetasone

Articles on Clobetasone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Clobetasone

Images of Clobetasone

Photos of Clobetasone

Podcasts & MP3s on Clobetasone

Videos on Clobetasone

Evidence Based Medicine

Cochrane Collaboration on Clobetasone

Bandolier on Clobetasone

TRIP on Clobetasone

Clinical Trials

Ongoing Trials on Clobetasone at Clinical Trials.gov

Trial results on Clobetasone

Clinical Trials on Clobetasone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Clobetasone

NICE Guidance on Clobetasone

NHS PRODIGY Guidance

FDA on Clobetasone

CDC on Clobetasone

Books

Books on Clobetasone

News

Clobetasone in the news

Be alerted to news on Clobetasone

News trends on Clobetasone

Commentary

Blogs on Clobetasone

Definitions

Definitions of Clobetasone

Patient Resources / Community

Patient resources on Clobetasone

Discussion groups on Clobetasone

Patient Handouts on Clobetasone

Directions to Hospitals Treating Clobetasone

Risk calculators and risk factors for Clobetasone

Healthcare Provider Resources

Symptoms of Clobetasone

Causes & Risk Factors for Clobetasone

Diagnostic studies for Clobetasone

Treatment of Clobetasone

Continuing Medical Education (CME)

CME Programs on Clobetasone

International

Clobetasone en Espanol

Clobetasone en Francais

Business

Clobetasone in the Marketplace

Patents on Clobetasone

Experimental / Informatics

List of terms related to Clobetasone

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Clobetasone is a corticosteroid used in dermatology, for treating such skin inflammation as seen in eczema and other forms of dermatitis, and ophthalmology.

It is available as clobetasone butyrate under the brand name Eumovate manufactured by GlaxoSmithKline.


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools